Skin cancer
According to the World Health Organisation both non-melanoma and melanoma skin cancers have been increasing over the past decades; we are now facing an epidemic of these conditions. How did we get to this stage? Various initiatives including the ABCDE of melanoma have been developed by prestigious institutions to improve awareness and diagnosis but there is still no improvement in the prevalence of melanoma. Why is prevention apparently not effective and how hopeful does the future look? In this section we are aiming to provide a skin cancer focus in our daily bibliography coverage.
#ASCO16 news about #melanoma #skincancer
Online now: CheckMate064-nivolumab then ipilimumab more beneficial, more tox vs reverse order in #melanoma https://t.co/dpiSm9c5uq #ASCO16
— The Lancet Oncology (@TheLancetOncol) June 4, 2016
#ASCO16 news about #melanoma #skincancer
#keytruda shows some early benefit in some but not all sarcoma patients –Dr D'Angelo #asco16 pic.twitter.com/dtbGrmzhJj
— Eric D Whitman, MD (@Melanoma_doctor) June 5, 2016
#ASCO16 news about #melanoma #skincancer
#ASCO16 Join Arie Crown Th. 2.15PM Pr Robert @GustaveRoussy KEYNOTE-001 Results: 3-y overall survival for pts w/pembro in advanced #melanoma
— GustaveRoussy (@GustaveRoussy) June 6, 2016
#ASCO16 news about #melanoma #skincancer
Predictive biomarkers for #checkpoint inhibitors, #immunotherapy, in #melanoma and #crc. https://t.co/Ewhdr0cFvU #ASCO16 @VUMChealth
— AJMC-Oncology (@EBOncology) June 6, 2016
Creams effective to treat superficial basal cell carcinoma medicalnewstoday.com/releases/31070… and @JIDJournal jidonline.org/article/S0022-… #skincancer #skin
Light-listening device could transform skin disease detection dermatologytimes.modernmedicine.com/dermatology-ti… #skincancer #skinimaging
RT @practiceupdate: .@ASCO : Pembrolizumab Improves Survival in #Melanoma ow.ly/qtXE300v2I0 #ASCO16 #skcsm
RT @MDAMelanomaOnc: Sat #ASCO16 poster 9548,M Rohlfs: BRAF +/ -MEK inhibition plus PD-1 checkpoint blockade for treatment of metastatic #me…
RT @MedscapeDerm: #ASCO16: findings from NEMO, other #Melanoma highlights. wb.md/1TYyVZH
#ASCO16 news about #melanoma #skincancer
In which patients with #melanoma should sentinel lymph node biopsy be pursued? https://t.co/WeFysq4uIg #ASCO16
— ASCO (@ASCO) June 4, 2016